Overall rank by patents
#5,140
Across all tracked assignees
USPTO PatentsView assignee record - 67 granted patents across 20 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B60N (SEATS SPECIALLY ADAPTED FOR VEHICLES; VEHICLE PASSENGER ACCOMMODATION NOT OTHERWISE PROVIDED FOR).
The verdict
Adient holds 67 US patents across 20 technology areas, rank #5,140 of 50,000 tracked assignees.
Adient US Llc has been granted 67 US utility patents between 2022 and 2025, placing Adient US Llc at rank #5,140 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.5 claims per patent with primary concentration in B60N (SEATS SPECIALLY ADAPTED FOR VEHICLES; VEHICLE PASSENGER ACCOMMODATION NOT OTHERWISE PROVIDED FOR). As a US Corporation, Adient US Llc is one of the more focused assignees in the PatentsView dataset. By volume, Adient sits between AGFA Healthcare Nv (67 patents, rank #5,136) and Beken Corporation (67 patents, rank #5,144) - the closest US assignees by grant volume. The composite Innovation Score of 57.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 67 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Adient US Llc's 12.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Adient US Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AGFA HEALTHCARE NV
67 patents
AMGEN RESEARCH (MUNICH) GMBH
67 patents
AMINI INNOVATION CORPORATION
67 patents
AREVA NP
67 patents
Ancestry.com Operations Inc.
67 patents
Arevo, Inc.
67 patents
Aviatrix Systems, Inc.
67 patents
Beken Corporation
67 patents
Adient US LLC
67 patents
What this shows Adient holds 67 patents at rank #5,140, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,140 in granted patent volume.
Other assignees with the most granted patents in Adient's primary technology class.
Adient's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
58 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 15 | 22.4% |
| 2023 | 15 | 22.4% |
| 2024 | 23 | 34.3% |
| 2025 | 14 | 20.9% |
Top 15 of 20 technology areas
Overall rank by patents
#5,140
Across all tracked assignees
57.9 out of 100
How to use this portfolio
Adient's 67 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.